share_log

Vanda Pharmaceuticals Granted U.S. Patent Titled 'Treatment of circadian rhythm disorders'

Vanda Pharmaceuticals Granted U.S. Patent Titled 'Treatment of circadian rhythm disorders'

万达制药公司获得名为“治疗昼夜节律紊乱”的美国专利
Benzinga Real-time News ·  2021/03/16 23:46

Vanda Pharmaceuticals Granted U.S. Patent Titled 'Treatment of circadian rhythm disorders'

万达制药公司获得名为“治疗昼夜节律紊乱”的美国专利

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发